Rho kinases in cardiovascular physiology and pathophysiology.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16484628.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have been found to regulate a wide range of fundamental cell functions such as contraction, motility, proliferation, and apoptosis. Abnormal activation of the RhoA/ROCK pathway has been observed in major cardiovascular disorders such as atherosclerosis, restenosis, hypertension, pulmonary hypertension, and cardiac hypertrophy. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of ROCK signaling and its roles in cardiovascular physiology and pathophysiology.
Medical subject headings
- Cardiovascular Diseases
- Cardiovascular Physiological Phenomena
- Cardiovascular System
- Intracellular Signaling Peptides and Proteins
- Protein Serine-Threonine Kinases